0.012359
0.007136
0.000000
0.000000
0.014271
0.000000
0.000000
0.000000
0.030084
0.000000
0.000000
0.000000
Favero-Retto, M.P.
Palmieri, L.C.
Lima, L.M.T.R.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
18
90.000
90.000
120.000
80.910
80.910
33.240
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
Cl -1
35.453
CHLORIDE ION
non-polymer
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
Zn 2
65.409
ZINC ION
non-polymer
NE
Eur J Pharm Biopharm
0353
0939-6411
85
1112
1121
10.1016/j.ejpb.2013.05.005
23692694
Structural meta-analysis of regular human insulin in pharmaceutical formulations.
2013
100
1
CCD
MAR CCD 165 mm
Si(111)
SINGLE WAVELENGTH
M
x-ray
1
1.0
D03B-MX1
LNLS
SYNCHROTRON
LNLS BEAMLINE D03B-MX1
2383.698
Insulin A chain
UNP residues 90-110
2
nat
polymer
3433.953
Insulin B chain
UNP residues 25-54
2
nat
polymer
65.409
ZINC ION
2
syn
non-polymer
35.453
CHLORIDE ION
2
syn
non-polymer
18.015
water
98
nat
water
no
no
GIVEQCCTSICSLYQLENYCN
GIVEQCCTSICSLYQLENYCN
A,C
polypeptide(L)
no
no
FVNQHLCGSHLVEALYLVCGERGFFYTPKT
FVNQHLCGSHLVEALYLVCGERGFFYTPKT
B,D
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
sample
9606
Homo sapiens
human
sample
9606
Homo sapiens
1
1.80
31.65
VAPOR DIFFUSION, HANGING DROP
5.5
0.1 M sodium phosphate, pH 5.5, 10% w/v PEG6000, cryoprotectant: mother liquor + 10% glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293K
293
software
repository
Initial release
Database references
Database references
Refinement description
1
0
2013-05-01
1
1
2013-06-12
1
2
2013-12-18
1
3
2017-11-15
_software.name
RCSB
Y
RCSB
2012-04-28
REL
REL
ZN
ZINC ION
CL
CHLORIDE ION
HOH
water
ZN
2
3
ZN
ZN
101
B
CL
1
4
CL
CL
102
B
ZN
1
3
ZN
ZN
101
D
CL
1
4
CL
CL
102
D
HOH
144
5
HOH
HOH
101
A
HOH
154
5
HOH
HOH
102
A
HOH
159
5
HOH
HOH
103
A
HOH
160
5
HOH
HOH
104
A
HOH
163
5
HOH
HOH
105
A
HOH
183
5
HOH
HOH
106
A
HOH
184
5
HOH
HOH
107
A
HOH
186
5
HOH
HOH
108
A
HOH
192
5
HOH
HOH
109
A
HOH
202
5
HOH
HOH
110
A
HOH
204
5
HOH
HOH
111
A
HOH
205
5
HOH
HOH
112
A
HOH
208
5
HOH
HOH
113
A
HOH
210
5
HOH
HOH
114
A
HOH
218
5
HOH
HOH
115
A
HOH
221
5
HOH
HOH
116
A
HOH
244
5
HOH
HOH
117
A
HOH
252
5
HOH
HOH
118
A
HOH
255
5
HOH
HOH
119
A
HOH
259
5
HOH
HOH
120
A
HOH
260
5
HOH
HOH
121
A
HOH
131
5
HOH
HOH
201
B
HOH
132
5
HOH
HOH
202
B
HOH
135
5
HOH
HOH
203
B
HOH
141
5
HOH
HOH
204
B
HOH
142
5
HOH
HOH
205
B
HOH
148
5
HOH
HOH
206
B
HOH
149
5
HOH
HOH
207
B
HOH
150
5
HOH
HOH
208
B
HOH
151
5
HOH
HOH
209
B
HOH
155
5
HOH
HOH
210
B
HOH
162
5
HOH
HOH
211
B
HOH
164
5
HOH
HOH
212
B
HOH
165
5
HOH
HOH
213
B
HOH
169
5
HOH
HOH
214
B
HOH
170
5
HOH
HOH
215
B
HOH
173
5
HOH
HOH
216
B
HOH
175
5
HOH
HOH
217
B
HOH
185
5
HOH
HOH
218
B
HOH
188
5
HOH
HOH
219
B
HOH
206
5
HOH
HOH
220
B
HOH
209
5
HOH
HOH
221
B
HOH
215
5
HOH
HOH
222
B
HOH
219
5
HOH
HOH
223
B
HOH
222
5
HOH
HOH
224
B
HOH
236
5
HOH
HOH
225
B
HOH
239
5
HOH
HOH
226
B
HOH
240
5
HOH
HOH
227
B
HOH
245
5
HOH
HOH
228
B
HOH
248
5
HOH
HOH
229
B
HOH
251
5
HOH
HOH
230
B
HOH
253
5
HOH
HOH
231
B
HOH
256
5
HOH
HOH
232
B
HOH
257
5
HOH
HOH
233
B
HOH
137
5
HOH
HOH
101
C
HOH
140
5
HOH
HOH
102
C
HOH
143
5
HOH
HOH
103
C
HOH
145
5
HOH
HOH
104
C
HOH
167
5
HOH
HOH
105
C
HOH
174
5
HOH
HOH
106
C
HOH
190
5
HOH
HOH
107
C
HOH
191
5
HOH
HOH
108
C
HOH
197
5
HOH
HOH
109
C
HOH
201
5
HOH
HOH
110
C
HOH
203
5
HOH
HOH
111
C
HOH
229
5
HOH
HOH
112
C
HOH
230
5
HOH
HOH
113
C
HOH
254
5
HOH
HOH
114
C
HOH
2
5
HOH
HOH
201
D
HOH
4
5
HOH
HOH
202
D
HOH
72
5
HOH
HOH
203
D
HOH
136
5
HOH
HOH
204
D
HOH
138
5
HOH
HOH
205
D
HOH
139
5
HOH
HOH
206
D
HOH
146
5
HOH
HOH
207
D
HOH
147
5
HOH
HOH
208
D
HOH
152
5
HOH
HOH
209
D
HOH
156
5
HOH
HOH
210
D
HOH
157
5
HOH
HOH
211
D
HOH
158
5
HOH
HOH
212
D
HOH
161
5
HOH
HOH
213
D
HOH
166
5
HOH
HOH
214
D
HOH
168
5
HOH
HOH
215
D
HOH
171
5
HOH
HOH
216
D
HOH
176
5
HOH
HOH
217
D
HOH
179
5
HOH
HOH
218
D
HOH
194
5
HOH
HOH
219
D
HOH
198
5
HOH
HOH
220
D
HOH
200
5
HOH
HOH
221
D
HOH
211
5
HOH
HOH
222
D
HOH
216
5
HOH
HOH
223
D
HOH
224
5
HOH
HOH
224
D
HOH
226
5
HOH
HOH
225
D
HOH
235
5
HOH
HOH
226
D
HOH
238
5
HOH
HOH
227
D
HOH
246
5
HOH
HOH
228
D
HOH
250
5
HOH
HOH
229
D
HOH
258
5
HOH
HOH
230
D
39.000
2.500
2.500
20.710
20.710
Phaser MODE: MR_AUTO
GLY
1
n
1
GLY
1
A
ILE
2
n
2
ILE
2
A
VAL
3
n
3
VAL
3
A
GLU
4
n
4
GLU
4
A
GLN
5
n
5
GLN
5
A
CYS
6
n
6
CYS
6
A
CYS
7
n
7
CYS
7
A
THR
8
n
8
THR
8
A
SER
9
n
9
SER
9
A
ILE
10
n
10
ILE
10
A
CYS
11
n
11
CYS
11
A
SER
12
n
12
SER
12
A
LEU
13
n
13
LEU
13
A
TYR
14
n
14
TYR
14
A
GLN
15
n
15
GLN
15
A
LEU
16
n
16
LEU
16
A
GLU
17
n
17
GLU
17
A
ASN
18
n
18
ASN
18
A
TYR
19
n
19
TYR
19
A
CYS
20
n
20
CYS
20
A
ASN
21
n
21
ASN
21
A
PHE
1
n
1
PHE
1
B
VAL
2
n
2
VAL
2
B
ASN
3
n
3
ASN
3
B
GLN
4
n
4
GLN
4
B
HIS
5
n
5
HIS
5
B
LEU
6
n
6
LEU
6
B
CYS
7
n
7
CYS
7
B
GLY
8
n
8
GLY
8
B
SER
9
n
9
SER
9
B
HIS
10
n
10
HIS
10
B
LEU
11
n
11
LEU
11
B
VAL
12
n
12
VAL
12
B
GLU
13
n
13
GLU
13
B
ALA
14
n
14
ALA
14
B
LEU
15
n
15
LEU
15
B
TYR
16
n
16
TYR
16
B
LEU
17
n
17
LEU
17
B
VAL
18
n
18
VAL
18
B
CYS
19
n
19
CYS
19
B
GLY
20
n
20
GLY
20
B
GLU
21
n
21
GLU
21
B
ARG
22
n
22
ARG
22
B
GLY
23
n
23
GLY
23
B
PHE
24
n
24
PHE
24
B
PHE
25
n
25
PHE
25
B
TYR
26
n
26
TYR
26
B
THR
27
n
27
THR
27
B
PRO
28
n
28
PRO
28
B
LYS
29
n
29
LYS
29
B
THR
30
n
30
THR
30
B
GLY
1
n
1
GLY
1
C
ILE
2
n
2
ILE
2
C
VAL
3
n
3
VAL
3
C
GLU
4
n
4
GLU
4
C
GLN
5
n
5
GLN
5
C
CYS
6
n
6
CYS
6
C
CYS
7
n
7
CYS
7
C
THR
8
n
8
THR
8
C
SER
9
n
9
SER
9
C
ILE
10
n
10
ILE
10
C
CYS
11
n
11
CYS
11
C
SER
12
n
12
SER
12
C
LEU
13
n
13
LEU
13
C
TYR
14
n
14
TYR
14
C
GLN
15
n
15
GLN
15
C
LEU
16
n
16
LEU
16
C
GLU
17
n
17
GLU
17
C
ASN
18
n
18
ASN
18
C
TYR
19
n
19
TYR
19
C
CYS
20
n
20
CYS
20
C
ASN
21
n
21
ASN
21
C
PHE
1
n
1
PHE
1
D
VAL
2
n
2
VAL
2
D
ASN
3
n
3
ASN
3
D
GLN
4
n
4
GLN
4
D
HIS
5
n
5
HIS
5
D
LEU
6
n
6
LEU
6
D
CYS
7
n
7
CYS
7
D
GLY
8
n
8
GLY
8
D
SER
9
n
9
SER
9
D
HIS
10
n
10
HIS
10
D
LEU
11
n
11
LEU
11
D
VAL
12
n
12
VAL
12
D
GLU
13
n
13
GLU
13
D
ALA
14
n
14
ALA
14
D
LEU
15
n
15
LEU
15
D
TYR
16
n
16
TYR
16
D
LEU
17
n
17
LEU
17
D
VAL
18
n
18
VAL
18
D
CYS
19
n
19
CYS
19
D
GLY
20
n
20
GLY
20
D
GLU
21
n
21
GLU
21
D
ARG
22
n
22
ARG
22
D
GLY
23
n
23
GLY
23
D
PHE
24
n
24
PHE
24
D
PHE
25
n
25
PHE
25
D
TYR
26
n
26
TYR
26
D
THR
27
n
27
THR
27
D
PRO
28
n
28
PRO
28
D
LYS
29
n
29
LYS
29
D
THR
30
n
30
THR
30
D
author_and_software_defined_assembly
PISA
12
dodecameric
21280
-376
10850
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
-0.5000000000
-0.8660254038
0.0000000000
0.8660254038
-0.5000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
2_555
-y,x-y,z
crystal symmetry operation
0.0000000000
0.0000000000
0.0000000000
-0.5000000000
0.8660254038
0.0000000000
-0.8660254038
-0.5000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
3_555
-x+y,-x,z
crystal symmetry operation
0.0000000000
0.0000000000
0.0000000000
A
N
CYS
11
A
N
CYS
11
B
O
GLN
4
B
O
GLN
4
B
N
TYR
26
B
N
TYR
26
D
O
PHE
24
D
O
PHE
24
1
B
ZN
101
E
ZN
1
B
CL
102
F
CL
1
D
ZN
101
G
ZN
1
B
HOH
227
J
HOH
1
C
C
ILE
CYS
10
11
-147.88
1
C
SER
9
A
-115.78
-117.12
1
C
SER
9
B
-116.16
-126.36
55.640
14.1289
3.220
0.0700
0.0400
0.0000
0.0700
0.0000
-0.1100
0.9080
0.8160
HYDROGENS HAVE BEEN USED IF PRESENT IN THE INPUT
U VALUES : REFINED INDIVIDUALLY
0.2875
0.2007
0.2086
2.300
40.45
330
3606
9.2
99.78
1.000
0.330
10.2200
0.2560
RANDOM
1
THROUGHOUT
0.0
MOLECULAR REPLACEMENT
0.7770
0.3720
0.8000
0.8000
1.2000
MAXIMUM LIKELIHOOD
BABINET MODEL WITH MASK
2.300
40.45
98
910
4
0
808
0.014
0.020
894
1.655
1.947
1224
9.017
5.000
111
37.796
24.048
42
18.288
15.000
140
18.080
15.000
3
0.105
0.200
135
0.006
0.021
696
0.2480
0.1800
2.360
19
257
276
20
100.0
2.300
40.455
4EWW
3608
3608
0.093
1
9.4
3.0
99.8
0.170
2.300
2.420
4.40
1590
530
0.170
1
3.0
100.0
0.143
2.420
2.570
4.90
1535
509
0.143
1
3.0
100.0
0.153
2.570
2.750
4.10
1374
457
0.153
1
3.0
100.0
0.086
2.750
2.970
8.10
1321
437
0.086
1
3.0
100.0
0.063
2.970
3.250
11.10
1243
410
0.063
1
3.0
100.0
0.124
3.250
3.640
3.50
1070
363
0.124
1
2.9
100.0
0.099
3.640
4.200
4.20
944
313
0.099
1
3.0
100.0
0.040
4.200
5.140
14.90
829
272
0.040
1
3.0
100.0
0.040
5.140
7.270
17.40
651
211
0.040
1
3.1
100.0
0.031
7.270
20.227
19.70
331
106
0.031
1
3.1
94.5
data reduction
Andrew G.W. Leslie
andrew@mrc-lmb.cam.ac.uk
http://www.mrc-lmb.cam.ac.uk/harry/mosflm/
MOSFLM
package
data scaling
Phil R. Evans
pre@mrc-lmb.cam.ac.uk
2011/05/18
Fortran_77
http://www.ccp4.ac.uk/dist/html/scala.html
SCALA
other
3.3.20
phasing
Randy J. Read
cimr-phaser@lists.cam.ac.uk
Wed Jun 24 14:00:05 2009
http://www-structmed.cimr.cam.ac.uk/phaser/
PHASER
program
2.1.4
refinement
Garib N. Murshudov
garib@ysbl.york.ac.uk
Fortran_77
http://www.ccp4.ac.uk/dist/html/refmac5.html
REFMAC
program
5.6.0117
data extraction
PDB
deposit@deposit.rcsb.org
April 22, 2011
C++
http://sw-tools.pdb.org/apps/PDB_EXTRACT/
PDB_EXTRACT
package
3.11
data collection
MAR345
Insulin A chain, Insulin B chain
Human Insulin
1
N
N
2
N
N
1
N
N
2
N
N
3
N
N
4
N
N
3
N
N
4
N
N
5
N
N
5
N
N
5
N
N
5
N
N
A
GLY
1
A
GLY
1
HELX_P
A
CYS
7
A
CYS
7
1
1
7
A
LEU
13
A
LEU
13
HELX_P
A
GLU
17
A
GLU
17
1
2
5
A
ASN
18
A
ASN
18
HELX_P
A
CYS
20
A
CYS
20
5
3
3
B
GLY
8
B
GLY
8
HELX_P
B
GLY
20
B
GLY
20
1
4
13
B
GLU
21
B
GLU
21
HELX_P
B
GLY
23
B
GLY
23
5
5
3
C
ILE
2
C
ILE
2
HELX_P
C
SER
9
C
SER
9
1
6
8
C
SER
12
C
SER
12
HELX_P
C
GLU
17
C
GLU
17
1
7
6
C
ASN
18
C
ASN
18
HELX_P
C
CYS
20
C
CYS
20
5
8
3
D
GLY
8
D
GLY
8
HELX_P
D
GLY
20
D
GLY
20
1
9
13
D
GLU
21
D
GLU
21
HELX_P
D
GLY
23
D
GLY
23
5
10
3
disulf
2.049
A
CYS
6
A
SG
CYS
6
1_555
A
CYS
11
A
SG
CYS
11
1_555
disulf
2.029
A
CYS
7
A
SG
CYS
7
1_555
B
CYS
7
B
SG
CYS
7
1_555
disulf
2.025
A
CYS
20
A
SG
CYS
20
1_555
B
CYS
19
B
SG
CYS
19
1_555
disulf
2.001
C
CYS
6
C
SG
CYS
6
1_555
C
CYS
11
C
SG
CYS
11
1_555
disulf
2.027
C
CYS
7
C
SG
CYS
7
1_555
D
CYS
7
D
SG
CYS
7
1_555
disulf
2.084
C
CYS
20
C
SG
CYS
20
1_555
D
CYS
19
D
SG
CYS
19
1_555
metalc
2.014
D
HIS
10
D
NE2
HIS
10
1_555
D
ZN
101
G
ZN
ZN
1_555
metalc
2.131
B
HIS
10
B
NE2
HIS
10
1_555
B
ZN
101
E
ZN
ZN
1_555
HORMONE
HORMONE
INS_HUMAN
UNP
1
90
P01308
GIVEQCCTSICSLYQLENYCN
INS_HUMAN
UNP
2
25
P01308
FVNQHLCGSHLVEALYLVCGERGFFYTPKT
90
110
4EWW
1
21
P01308
A
1
1
21
25
54
4EWW
1
30
P01308
B
2
1
30
90
110
4EWW
1
21
P01308
C
1
1
21
25
54
4EWW
1
30
P01308
D
2
1
30
2
2
anti-parallel
anti-parallel
A
CYS
11
A
CYS
11
A
SER
12
A
SER
12
B
ASN
3
B
ASN
3
B
GLN
4
B
GLN
4
B
PHE
24
B
PHE
24
B
TYR
26
B
TYR
26
D
PHE
24
D
PHE
24
D
TYR
26
D
TYR
26
BINDING SITE FOR RESIDUE ZN B 101
Software
6
BINDING SITE FOR RESIDUE CL B 102
Software
3
BINDING SITE FOR RESIDUE ZN D 101
Software
6
BINDING SITE FOR RESIDUE CL D 102
Software
5
B
HIS
10
B
HIS
10
6
2_555
B
HIS
10
B
HIS
10
6
3_555
B
HIS
10
B
HIS
10
6
1_555
B
CL
102
F
CL
6
2_555
B
CL
102
F
CL
6
3_555
B
CL
102
F
CL
6
1_555
B
ZN
101
E
ZN
3
1_555
B
ZN
101
E
ZN
3
2_555
B
ZN
101
E
ZN
3
3_555
D
HIS
10
D
HIS
10
6
3_555
D
HIS
10
D
HIS
10
6
2_555
D
HIS
10
D
HIS
10
6
1_555
D
CL
102
H
CL
6
3_555
D
CL
102
H
CL
6
2_555
D
CL
102
H
CL
6
1_555
D
ZN
101
G
ZN
5
1_555
D
ZN
101
G
ZN
5
2_555
D
ZN
101
G
ZN
5
3_555
D
HOH
226
L
HOH
5
1_555
D
HOH
226
L
HOH
5
2_555
146
H 3